Paolo Denti | A (PK) Study in Scarlet: Investigating Target Concentrations

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #18 | Lauren Tompkins

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #17 | Laura Dickinson

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #16 | Mackenzie L. Cottrell

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #15 | Amanda Schauer

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #14 | Pierre Giguere

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #13 | Samantha Robertson

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #12 | Shahid Bukhari

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #11 | Jessica Cusato

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #10 | Renos Keniyopoullos

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #9 | Naveed Shaik

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #8 | Jeihun Kuack

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #7 | Lena Van Der Wekken

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #6 | Tim Cressey

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #5 | Kristina Brooks

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #3 | Caroline Solas Chesneau

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Abstract Oral Presentation #2 | Anne Kamphuis

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Oral Abstract Presentation #1 | Mattia Berton

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Saye Khoo | Tissue-Specific Pharmacology: How Clinically Important Is It

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Charles Flexner | Tissue-Specific Pharmacology: Knowledge and Knowledge Gaps

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Simon Portsmouth | Pharmacologic Data on New and Pipeline Drugs - Shionogi Inc.

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Alice Pau | A Global Collaboration to Harmonize Guidelines for Clinical Management of Ritonavir-Boosted Nirmatrelvir DDIs

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Elin Lindhagen | Harmonization of DDI Guidelines Among Different Regulatory Agencies: Challenges and Opportunities

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023

Catia Marzolini | Short Versus Extended Nirmatrelvir/R Treatment Course and Ensitrelvir: How Do DDIs Differ?

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023